Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients.
Mignogna C, Staropoli N, Botta C, De Marco C, Rizzuto A, Morelli M, Di Cello A, Franco R, Camastra C, Presta I, Malara N, Salvino A, Tassone P, Tagliaferri P, Barni T, Donato G, Di Vito A.
Mignogna C, et al. Among authors: malara n.
J Ovarian Res. 2016 May 21;9(1):31. doi: 10.1186/s13048-016-0238-7.
J Ovarian Res. 2016.
PMID: 27209210
Free PMC article.